196 related articles for article (PubMed ID: 27323780)
1. Gastrin-induced miR-222 promotes gastric tumor development by suppressing p27kip1.
Lloyd KA; Moore AR; Parsons BN; O'Hara A; Boyce M; Dockray GJ; Varro A; Pritchard DM
Oncotarget; 2016 Jul; 7(29):45462-45478. PubMed ID: 27323780
[TBL] [Abstract][Full Text] [Related]
2. Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors.
Lloyd KA; Parsons BN; Burkitt MD; Moore AR; Papoutsopoulou S; Boyce M; Duckworth CA; Exarchou K; Howes N; Rainbow L; Fang Y; Oxvig C; Dodd S; Varro A; Hall N; Pritchard DM
Cell Mol Gastroenterol Hepatol; 2020; 10(1):113-132. PubMed ID: 32004755
[TBL] [Abstract][Full Text] [Related]
3. MiR-320a inhibits gastric carcinoma by targeting activity in the FoxM1-P27KIP1 axis.
Wang Y; Zeng J; Pan J; Geng X; Li L; Wu J; Song P; Wang Y; Liu J; Wang L
Oncotarget; 2016 May; 7(20):29275-86. PubMed ID: 27086911
[TBL] [Abstract][Full Text] [Related]
4. Deletion of
Sundaresan S; Kang AJ; Hayes MM; Choi EK; Merchant JL
Gut; 2017 Jun; 66(6):1012-1021. PubMed ID: 26860771
[TBL] [Abstract][Full Text] [Related]
5. The cytoprotective protein clusterin is overexpressed in hypergastrinemic rodent models of oxyntic preneoplasia and promotes gastric cancer cell survival.
Vange P; Bruland T; Doseth B; Fossmark R; Sousa MML; Beisvag V; Sørdal Ø; Qvigstad G; Waldum HL; Sandvik AK; Bakke I
PLoS One; 2017; 12(9):e0184514. PubMed ID: 28902909
[TBL] [Abstract][Full Text] [Related]
6. Netazepide, a gastrin receptor antagonist, normalises tumour biomarkers and causes regression of type 1 gastric neuroendocrine tumours in a nonrandomised trial of patients with chronic atrophic gastritis.
Moore AR; Boyce M; Steele IA; Campbell F; Varro A; Pritchard DM
PLoS One; 2013; 8(10):e76462. PubMed ID: 24098507
[TBL] [Abstract][Full Text] [Related]
7. Connective tissue growth factor is activated by gastrin and involved in gastrin-induced migration and invasion.
Bhandari S; Bakke I; Kumar J; Beisvag V; Sandvik AK; Thommesen L; Varro A; Nørsett KG
Biochem Biophys Res Commun; 2016 Jun; 475(1):119-24. PubMed ID: 27179776
[TBL] [Abstract][Full Text] [Related]
8. MiR-196a is upregulated in gastric cancer and promotes cell proliferation by downregulating p27(kip1).
Sun M; Liu XH; Li JH; Yang JS; Zhang EB; Yin DD; Liu ZL; Zhou J; Ding Y; Li SQ; Wang ZX; Cao XF; De W
Mol Cancer Ther; 2012 Apr; 11(4):842-52. PubMed ID: 22343731
[TBL] [Abstract][Full Text] [Related]
9. Gastrin activates autophagy and increases migration and survival of gastric adenocarcinoma cells.
Rao SV; Solum G; Niederdorfer B; Nørsett KG; Bjørkøy G; Thommesen L
BMC Cancer; 2017 Jan; 17(1):68. PubMed ID: 28109268
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of Gastric NETs: Role of Gastrin and Menin.
Sundaresan S; Kang AJ; Merchant JL
Curr Gastroenterol Rep; 2017 Jul; 19(7):32. PubMed ID: 28608155
[TBL] [Abstract][Full Text] [Related]
11. Gastrin upregulates the prosurvival factor secretory clusterin in adenocarcinoma cells and in oxyntic mucosa of hypergastrinemic rats.
Fjeldbo CS; Bakke I; Erlandsen SE; Holmseth J; Lægreid A; Sandvik AK; Thommesen L; Bruland T
Am J Physiol Gastrointest Liver Physiol; 2012 Jan; 302(1):G21-33. PubMed ID: 21995960
[TBL] [Abstract][Full Text] [Related]
12. Gastrin induces parathyroid hormone-like hormone expression in gastric parietal cells.
Al Menhali A; Keeley TM; Demitrack ES; Samuelson LC
Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G649-G657. PubMed ID: 28408643
[TBL] [Abstract][Full Text] [Related]
13. Expression of the Cholecystokinin-B Receptor in Neoplastic Gastric Cells.
Mjønes P; Nordrum IS; Sørdal Ø; Sagatun L; Fossmark R; Sandvik A; Waldum HL
Horm Cancer; 2018 Feb; 9(1):40-54. PubMed ID: 28980157
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-182 targets cAMP-responsive element-binding protein 1 and suppresses cell growth in human gastric adenocarcinoma.
Kong WQ; Bai R; Liu T; Cai CL; Liu M; Li X; Tang H
FEBS J; 2012 Apr; 279(7):1252-60. PubMed ID: 22325466
[TBL] [Abstract][Full Text] [Related]
15. miR-449 inhibits cell proliferation and is down-regulated in gastric cancer.
Bou Kheir T; Futoma-Kazmierczak E; Jacobsen A; Krogh A; Bardram L; Hother C; Grønbæk K; Federspiel B; Lund AH; Friis-Hansen L
Mol Cancer; 2011 Mar; 10():29. PubMed ID: 21418558
[TBL] [Abstract][Full Text] [Related]
16. Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis.
Boyce M; Moore AR; Sagatun L; Parsons BN; Varro A; Campbell F; Fossmark R; Waldum HL; Pritchard DM
Br J Clin Pharmacol; 2017 Mar; 83(3):466-475. PubMed ID: 27704617
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-206: Effective Inhibition of Gastric Cancer Progression through the c-Met Pathway.
Zheng Z; Yan D; Chen X; Huang H; Chen K; Li G; Zhou L; Zheng D; Tu L; Dong XD
PLoS One; 2015; 10(7):e0128751. PubMed ID: 26186594
[TBL] [Abstract][Full Text] [Related]
18. Importance of gastrin in the pathogenesis and treatment of gastric tumors.
Burkitt MD; Varro A; Pritchard DM
World J Gastroenterol; 2009 Jan; 15(1):1-16. PubMed ID: 19115463
[TBL] [Abstract][Full Text] [Related]
19. Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacter-induced gastric cancer.
Takaishi S; Cui G; Frederick DM; Carlson JE; Houghton J; Varro A; Dockray GJ; Ge Z; Whary MT; Rogers AB; Fox JG; Wang TC
Gastroenterology; 2005 Jun; 128(7):1965-83. PubMed ID: 15940630
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth.
He XP; Shao Y; Li XL; Xu W; Chen GS; Sun HH; Xu HC; Xu X; Tang D; Zheng XF; Xue YP; Huang GC; Sun WH
FEBS J; 2012 Nov; 279(22):4201-12. PubMed ID: 23013439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
